Gene · 7939
Papers2,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights into the Effect of Aggregate Sizes on the Soil Radiation Interaction Properties Based on X-ray Fluorescence. | Int J Environ Res Public Health | 2022 | 36429374 | PubTator, text mining | PubMed |
| Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: Relevance to Pseudoexfoliation Glaucoma. | Biomolecules | 2022 | 36421707 | PubTator, text mining | PubMed |
| Natural Materials for 3D Printing and Their Applications. | Gels | 2022 | 36421570 | PubTator, text mining | PubMed |
| Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies. | Biology (Basel) | 2022 | 36421393 | PubTator, text mining | PubMed |
| Tip60-mediated H2A.Z acetylation promotes neuronal fate specification and bivalent gene activation. | Mol Cell | 2022 | 36417913 | PubTator, text mining | PubMed |
| Species-Based Differences in Mechanical Properties, Cytocompatibility, and Printability of Methacrylated Collagen Hydrogels. | Biomacromolecules | 2022 | 36417692 | PubTator, text mining | PubMed |
| The yin/yang balance of the MHC-self-immunopeptidome. | Front Immunol | 2022 | 36405763 | PubTator, text mining | PubMed |
| Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19. | Front Immunol | 2022 | 36405747 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression. | Front Immunol | 2022 | 36405712 | PubTator, text mining | PubMed |
| Biomarkers of sequela in adult patients convalescing from COVID-19. | Adv Biomark Sci Technol | 2022 | 36404876 | PubTator, text mining | PubMed |
| A Multifunctional 3D Bioprinting System for Construction of Complex Tissue Structure Scaffolds: Design and Application. | Int J Bioprint | 2022 | 36404789 | PubTator, text mining | PubMed |
| Recombinant Human Collagen-Based Bioinks for the 3D Bioprinting of Full-thickness Human Skin Equivalent. | Int J Bioprint | 2022 | 36404779 | PubTator, text mining | PubMed |
| Morphometric Study for C1 Pedicle Screw Placement in Thai Patients. | Asian J Neurosurg | 2022 | 36398178 | PubTator, text mining | PubMed |
| Is subcutaneous adipose tissue expansion in people living with lipedema healthier and reflected by circulating parameters? | Front Endocrinol (Lausanne) | 2022 | 36387874 | PubTator, text mining | PubMed |
| Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation. | STAR Protoc | 2022 | 36386869 | PubTator, text mining | PubMed |
| CTLA4 Gene Polymorphism and its Association with Disease Occurrence, Clinical Manifestations, Serum Markers and Cytokine Levels in SLE Patients from North India. | Indian J Dermatol | 2022 | 36386077 | PubTator, text mining | PubMed |
| In vitromodel to study confined osteocyte networks exposed to flow-induced mechanical stimuli. | Biomed Mater | 2022 | 36384043 | PubTator, text mining | PubMed |
| Neratinib plus capecitabine versus lapatinib plus capecitabine as the third-line therapy for HER2-positive metastatic breast cancer in China: a cost-effectiveness analysis. | BMJ Open | 2022 | 36379662 | PubTator, text mining | PubMed |
| Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay. | Clin Proteomics | 2022 | 36376783 | PubTator, text mining | PubMed |
| Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation. | BMC Infect Dis | 2022 | 36368931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7939/papers?page=35